Residual Solvent (ICH Q3C)
Residual solvents are organic solvents from synthesis or formulation that remain in the API or drug product. ICH Q3C classifies them by toxicity and sets permitted daily exposure (PDE) limits; USP <467> and Ph. Eur. 2.4.24 prescribe the measurement.
01What Q3C covers
Synthesis, recrystallisation and granulation often use organic solvents. Trace amounts remain in the final product unless deliberately removed. ICH Q3C sets a risk-based limit framework: class 1 solvents should be avoided; class 2 are limited by PDE (Permitted Daily Exposure); class 3 are generally regarded safe up to 5,000 ppm.
- Class 1: known carcinogens/toxics — benzene, CCl4 — must be avoided.
- Class 2: PDE-driven — methanol 30 mg/day, toluene 8.9 mg/day, methylene chloride 6 mg/day.
- Class 3: ≤ 5,000 ppm by Option 1 (or higher if justified by Option 2).
- Option 1 = ppm cap; Option 2 = mass per day across all sources.
- Limit applies to drug product, not just API — calculated by max daily dose.
02Class limits at a glance
| Class | Example | Q3C limit |
|---|---|---|
| Class 1 | Benzene | 2 ppm |
| Class 1 | CCl4 | 4 ppm |
| Class 2 | Methanol | 3,000 ppm (option 1) |
| Class 2 | Methylene chloride | 600 ppm |
| Class 2 | Toluene | 890 ppm |
| Class 3 | Ethanol, acetone, ethyl acetate | ≤ 5,000 ppm |
03Execution and controls
- Identify all solvents used in synthesis and formulation.
- Calculate spec from Q3C PDE and max daily dose.
- Validate drying step to remove solvents to spec.
- Test by GC headspace per USP <467>.
- Carry forward solvent exposure from API into drug product calculation.
04Common mistakes
- Treating LOD as solvent compliance — wrong test.
- Forgetting solvent carried from API into drug product.
- Using Option 1 limits without verifying total daily exposure.
- Not specifying class 1 absence test where class 1 was used in process.
- No GC method validation — release decisions on unvalidated data.
05Cross-industry examples
- API plants — drying spec defined by Q3C requirements.
- Solid-dose drug product — carryover from API specs included.
- Biopharma — limited solvent exposure; testing risk-based.
- Veterinary pharma — analogous frameworks (VICH GL18).
- Specialty chemical APIs for diagnostics.
06How V5 Ultimate handles residual solvents
Frequently asked questions
Q.Option 1 vs Option 2?+
Option 1 is a simple ppm cap on each solvent. Option 2 sums mass-per-day across all sources against the PDE — more permissive but more complex.
Q.What method tests residual solvents?+
GC headspace per USP <467> or Ph. Eur. 2.4.24.
Q.Do I need to test solvents not used?+
Not by Q3C; a risk assessment justifies omission.
Q.How is API carryover handled?+
API solvent levels carry forward into drug product calculation per max daily dose.
Q.What about class 1 absence?+
If a class 1 solvent was ever used in synthesis, an absence-or-limit test must be in the release spec.
Primary sources
Further reading
V5 Ultimate ships with the Residual Solvent (ICH Q3C) controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.